FDA Inspection 1240862 — Octapharma Produktionsgesellschaft Deutschland mbH
The FDA completed an inspection of Octapharma Produktionsgesellschaft Deutschland mbH on Jun 11, 2024 in Springe. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 11, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Springe (Germany)